To improve chemotherapy dosing, engineers designed CLAUDIA, a way to continuously measure how much drug is in a patient's system during hours-long infusion. When cancer patients undergo chemotherapy, ...

Cancer cells frequently develop the ability to expel anticancer drugs before they can work—a phenomenon called multidrug resistance (MDR)—which is one of the leading reasons why chemotherapy fails in ...

Key FDA findings: Polymer-to-drug ratios in dissolvable microneedles altered drug release speeds while maintaining penetration ability. Mechanical strength boost: Higher polymer content increased ...

HANGZHOU, China, May 8, 2026 /PRNewswire/ -- Chance Pharmaceuticals ("Chance" or "Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative ...

In the fight against antimicrobial resistance, pharmaceutical and biomedical research is increasingly turning toward nanotechnology to enhance the ...

CHICAGO, IL (May 5, 2026) — A swarm of tiny, shape-changing, all-metal robots might someday deliver drugs and capture biopsy samples painlessly and then safely dissolve without the need for extraction ...

In 2024, Insulet shared results from its landmark SECURE-T2D pivotal trial, demonstrating improved glycemic outcomes with Omnipod 5 compared with prior insulin injection or pump therapy in adults with ...

Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced that it will host a conference ...

Functional genomics is central to modern drug discovery, yet high attrition rates persist. In this article, Dr Salman ...

Established in 2025 and headquartered in the prestigious Zhongbei High-tech Industrial Development Zone of Taiyuan City, Chenglixiang is more than a supplier; it is a catalyst for pharmaceutical ...

How reorganizing existing drugs and vaccine components can dramatically alter their potency, selectivity, and even their ...

The oral presentation, titled, “¹⁸⁶Rhenium-Nanoliposomes (¹⁸⁶RNL) for the Treatment of Leptomeningeal Metastases: Translational Insights from Clinical and Preclinical Models,” was delivered by ...